# Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®

> **NCT06073600** · PHASE1 · COMPLETED · sponsor: **Reseach Laboratory of Clinical and Experimental Pharmacology** · enrollment: 18 (actual)

## Conditions studied

- Fed Conditions

## Interventions

- **DRUG:** Metformin / Vildagliptin Reference Film Coated Tablets (1000 mg / 50 mg) (Galvumet®)
- **DRUG:** Metformin / Vildagliptin Test Film Coated Tablets (1000 mg / 50 mg)

## Key facts

- **NCT ID:** NCT06073600
- **Lead sponsor:** Reseach Laboratory of Clinical and Experimental Pharmacology
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-20
- **Primary completion:** 2022-09-09
- **Final completion:** 2022-11-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06073600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06073600, "Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06073600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*